Molecular Templates hitches with Alnylam on RNAi delivery; PolyPid introduced new drug carriers;

> Molecular Templates a biopharmaceutical company developing what it calls a new class of small biologic therapies called Engineered Toxin Bodies has entered into a research collaboration with Alnylam Pharmaceuticals, which will  evaluate and develop Molecular Templates' technology for targeted delivery of RNAi therapies. No financial terms were disclosed. Release

> PolyPid has introduced a new family of drug carriers based on a melding of two drug delivery systems: polymers and lipid-based systems. The PolyPid carrier carrier can be tailored to small molecules, peptides, protein and nucleic acids-based drugs. Story

> Acrux receives boost from Europe for drug delivery technology for dogs. Item

> Independent clinical study validates Nanologica's new drug carrier material for oral use. Nanologica release

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.